share_log

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

CVS Health | 13F-HR: Information required of institutional investment managers pursuant to Section 13(f)

西维斯健康 | 13F-HR:投资机构季度报告
美股SEC公告 ·  05/04 04:32

Moomoo AI 已提取核心信息

CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the first quarter ended March 31, 2024. The filing, signed by Investment Manager Michael Motolo on May 3, 2024, in Woonsocket, RI, includes a total of 6 holdings with a combined value of $211,778,622. The Form 13F filing, which is a quarterly report filed by institutional investment managers to disclose their U.S. equity holdings, indicates that CVS Health Corp is the sole reporting manager for these holdings, as no other included managers are listed in the report.
CVS Health Corp has submitted its Form 13F filing to the Securities and Exchange Commission (SEC) for the first quarter ended March 31, 2024. The filing, signed by Investment Manager Michael Motolo on May 3, 2024, in Woonsocket, RI, includes a total of 6 holdings with a combined value of $211,778,622. The Form 13F filing, which is a quarterly report filed by institutional investment managers to disclose their U.S. equity holdings, indicates that CVS Health Corp is the sole reporting manager for these holdings, as no other included managers are listed in the report.
CVS Health Corp已向美国证券交易委员会(SEC)提交了截至2024年3月31日的第一季度的13F表格。该文件由投资经理迈克尔·莫托洛于2024年5月3日在罗得岛州文索克特签署,共包括6笔持股,总价值为211,778,622美元。13F表文件是机构投资经理为披露其持有的美国股票而提交的季度报告。该文件表明,CVS Health Corp是这些持股的唯一申报管理公司,因为报告中没有列出其他纳入的管理公司。
CVS Health Corp已向美国证券交易委员会(SEC)提交了截至2024年3月31日的第一季度的13F表格。该文件由投资经理迈克尔·莫托洛于2024年5月3日在罗得岛州文索克特签署,共包括6笔持股,总价值为211,778,622美元。13F表文件是机构投资经理为披露其持有的美国股票而提交的季度报告。该文件表明,CVS Health Corp是这些持股的唯一申报管理公司,因为报告中没有列出其他纳入的管理公司。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息